Capital Markets Day
Thursday 25th of June, 2026 | 9:00 AM EDT / 15:00 CEST
St. Regis Hotel, New York & Live Webcast
Featuring discussions with key opinion leaders and presentations by Hansa’s management team.
Click Here to Register & Attend
Investors
OMX Stockholm
( %)
HNSA SEK
Some content on this page is only available in English. All material required under applicable law, regulation or code is available in English and Swedish.
Calendar
Upcoming events
25Jun
Hansa Biopharma Capital Markets Day
22Jul
Interim Report for January-June 2026
05Nov
Interim Report for January-September 2026
Press releases
Our latest press releases
Hansa Biopharma appoints Adam Cutler as new Chief Financial Officer
15/06/2026
Hansa Biopharma invite to Capital Markets Day 2026 in New York
12/06/2026
Hansa Biopharma appoints Fredrik Röök as VP Business Development
10/06/2026
Hansa Biopharma participating in Jefferies Global Healthcare Conference in New York
02/06/2026
Hansa Biopharma in brief
Hansa Biopharma is a pioneering commercial-stage biopharmaceutical company on a mission to develop and commercialize innovative, lifesaving and life altering treatments for patients with rare immunological conditions.
